Overall Technical outlook

Price Summary

ZYDUSLIFE's shares experienced a significant -2.09% tumble, indicating a poor market performance.
Zydus Lifesciences Limited's stock opened at 910.9 on 2026-04-30, surged to 915.4, dropped to 890.4, and ended -2.09% down at 891.9, with 986123 shares traded.
During the 52-week span, the stock hit a high of 1047.85 and a low of 860.6.
Analysts expect the price of ZYDUSLIFE to vary between 800.0 and 1140.0, with an average expected price near 985.4138.

Technicals

Support and Resistance: With the current price at 891.9, support is found at 864.25 and resistance at 901.45. These levels indicate where buyers might step in at 864.25, while sellers could limit gains at 901.45, defining a trading boundary for Zydus Lifesciences Limited.
ZYDUSLIFE supportResistance d57bc5
Support/Resistance for ZYDUSLIFE


Aroon: The current state of the AROON is neutral, offering no clear signals of movement in either direction. This suggests a potential pause in market activity, with no strong trend emerging at the moment.
ZYDUSLIFE aroon d57bc5
Aroon chart for Zydus Lifesciences Limited


Bol. Bands: The current reading of the BOLL BANDS indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
ZYDUSLIFE bbands d57bc5
Bolinger Bands chart for Zydus Lifesciences Limited


Parabolic SAR: The PSAR remains bearish for Zydus Lifesciences Limited, establishing a crucial resistance level that could hinder any bullish attempts. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult for prices to rise.
ZYDUSLIFE psar d57bc5
Parabolic Stop and Reverse chart for Zydus Lifesciences Limited


Stochastic: The STOCHASTIC is in a neutral stance for ZYDUSLIFE, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
ZYDUSLIFE stoch d57bc5
Stochastic chart for Zydus Lifesciences Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 period moving averages reflects a bearish trend, signaling a downtrend for ZYDUSLIFE. Despite this, the slower SMAs appear to be losing momentum, which could indicate a potential pivot. This weakening in the bearish trend may suggest that the market is preparing for a bullish reversal, with a possible shift in direction occurring soon.
ZYDUSLIFE trippleSMA d57bc5
Tripple SMA chart for Zydus Lifesciences Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.